Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2015; 5(11): 055-062


Chitosan Liposomal microspheres for Ricinoleic acid Encapsulation

Rihab Abd EL Azeem, Ahmed A. Nada, Ahmed S. Montaser.

Abstract
Ricinoleic acid (RA) is a C18 fatty acid (FA) with a double bond at the C 9 position and a hydroxyl group at the C(12) position (cis-12-hydroxyoctadeca-9-enoic acid). Recently, RA has been reported as a pro/anti-inflammatory and analgesic agent for topical applications to be considered as an alternative to irritant substances that relive pain. However, RA when it is exposed to air, it reacts with the oxygen and decomposes into short-chain aldehydes and ketones. Moreover, pathologically, small amount of anaesthetic agent acts on peripheral nerves, producing reversible block in transmission of peripheral nerves impulses. However, larger amounts effect potentially in the central nervous system and may cause cardiac arrest. Accordingly, extended release formulations for local anaesthetic agent such as encapsulation, are highly demanded if the drug will be used for long period. In this work, ricinoleic acid, extracted and characterized, was encapsulated into a new matrix made of phospholipid liposomes and chitosan to protect and control RA release. RA release was controlled by crosslinking the matrices using glutaraldehyde. Spectral and morphology analysis are used to characterize the produced microshpers. The cytotoxicity test is considered to examine the final product biocompatibility. The encapsulation efficiency was investigated by UV- Visible spectroscopy.

Key words: Ricinoleic acid; anti-inflammatory; encapsulation; microspheres; drug delivery.



Share this Article


Advertisement
Journal of Complementary Medicine Research

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.